Interdisciplinary team reveals how Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy

FHS
June 18, 2024
4:35 pm

A new paper from an interdisciplinary team at MUSC Hollings Cancer Center describes how the bacteria Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer tumors to become resistant to the drug’s effects.

The Path to Value-Based Care through Patient Engagement

Joy Avery, MSN, RN, SVP, Clinical Strategy, CipherHealth Donna Pritchard, DNP, FNP-BC, MSN, RN, VP, Clinical Services, CipherHealth The transformation of the healthcare landscape is

November 28, 2023

Study offers insights into chronic fatigue syndrome and its resemblance to long COVID-19

The study, which will serve “as a guide for rapid diagnosis”, provides valuable information for the medical community, in particular in primary care.

September 20, 2024

Visual cortex’s impact on motor skill acquisition

You join a swing dance class, and at first you’re all left feet. But – slowly, eyes glued to the teacher – you pick up

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.